About Premas Life Sciences
Premas Life Sciences is a company based in Delhi (India) founded in 2005 by Avijit Das and Praveen Gupta. It operates as a B2B. The company has 88 employees as of March 31, 2023. Premas Life Sciences offers products and services including Novaseq 6000, Chromium Controller, and BioXp 3250. Premas Life Sciences operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
- Headquarter Delhi, India
- Employees 88 as on 31 Mar, 2023
- Founders Avijit Das, Praveen Gupta
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Premas Life Sciences Private Limited
- Date of Incorporation 15 Apr, 2011
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$31.28 M (USD)-21.23as on Mar 31, 2023
-
Net Profit
$4.48 M (USD)-45.23as on Mar 31, 2023
-
EBITDA
$5.89 M (USD)-45.72as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
88
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Premas Life Sciences
Premas Life Sciences offers a comprehensive portfolio of products and services, including Novaseq 6000, Chromium Controller, and BioXp 3250.
Enables broad and deep genomic sequencing for research discoveries.
Provides single cell resolution for maximizing biological insights.
Automates gene synthesis for accelerated research in medicine and biologics.
People of Premas Life Sciences
Unlock access to complete
Funding Insights of Premas Life Sciences
Detailed funding history for Premas Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Premas Life Sciences
Investment portfolio details for Premas Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Premas Life Sciences
Detailed financials for Premas Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Premas Life Sciences Comparisons
Peer comparison for Premas Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Premas Life Sciences
Premas Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| Locked | Locked | Locked |
Provider of genome analysis solutions to researchers and clinicians
|
Detailed competitors of Premas Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Premas Life Sciences
Complete news archive for Premas Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Premas Life Sciences
Premas Life Sciences was founded in 2005.
Premas Life Sciences is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Avijit Das is the current CEO of Premas Life Sciences. They have also founded this company.
As of Mar 31, 2023, the latest employee count at Premas Life Sciences is 88.
Annual revenue of Premas Life Sciences is $31.28M as on Mar 31, 2023.
Premas Life Sciences, based in Delhi, India, provides advanced tools and technologies for genomics, proteomics, and synthetic biology. They partner with global brands like Illumina and 10X Genomics to supply sequencing platforms and gene editing solutions. The company focuses on enabling research in human health, agriculture, and biopharma through excellent customer support and integrations. Serving researchers and clinical organizations, they emphasize timely innovations and high-quality products to accelerate scientific discoveries.
Premas Life Sciences offers Novaseq 6000, Chromium Controller, and BioXp 3250.